3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
135
Neoplasms
37
Pancreatic Neoplasms
34
Stomach Neoplasms
27
Colonic Neoplasms
23
Neoplasm Metastasis
20
Rectal Neoplasms
17
Carcinoma, Non-Small-Cell Lung
15
Esophageal Neoplasms
10
Cholangiocarcinoma
10
Adenocarcinoma
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Biliary Tract Neoplasms
8
Adenocarcinoma Of Esophagus
8
Ovarian Neoplasms
7
Triple Negative Breast Neoplasms
6
Gallbladder Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Gastrointestinal Neoplasms
5
Digestive System Neoplasms
5
Breast Neoplasms
5
Advanced Solid Tumors
5
Squamous Cell Carcinoma of Head and Neck
4
Solid Tumors
4
Melanoma
4
Intestinal Neoplasms
4
Carcinoma, Pancreatic Ductal
4
Carcinoma, Hepatocellular
4
Advanced Solid Tumor
4
Small Cell Lung Carcinoma
3
Interventions
Gemcitabine
2
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Locally Advanced Pancreatic Cancer
×
Leucovorin
×
Clear all
NCT05466799
2026-02-13
TRIPP-FFX
OncoSil Medical Limited
Phase 2
Active not recruiting
88 enrolled